Related by context. All words. (Click for frequent words.) 75 Tykerb lapatinib 75 Aflibercept 73 Initiates Enrollment 73 initiated Phase Ib 73 SinuNase ™ 73 Completes Patient Enrollment 73 Ixempra 73 TELINTRA R 72 GVAX ® 72 volociximab 72 LymphoStat B TM 72 mertansine 72 midstage clinical 72 PDE4 inhibitor 72 Phase #b/#a clinical 72 beta 1a 72 Canvaxin 72 targeted radiotherapeutic 71 RTP #i 71 GW# [003] 71 Phase Ib IIa 71 novel therapeutic antibodies 71 Panzem R 71 Initiates Clinical Trial 71 OvaRex 71 non nucleoside inhibitor 71 baminercept 71 Xelox 71 Initiates Phase III 71 Panzem R NCD 71 docetaxel Taxotere R 71 brivanib 71 Trastuzumab DM1 71 cathepsin K inhibitor 71 reslizumab 71 Tesmilifene 70 Allovectin 7 70 Nexavar sorafenib 70 midstage trials 70 Albugon 70 sitaxsentan 70 Silodosin 70 acyclovir Lauriad R 70 Initiates Phase II 70 KNS # 70 Begins Dosing 70 novel histone deacetylase 70 RANK Ligand inhibitor 70 Gemzar gemcitabine 70 Tocosol Paclitaxel 70 virus HCV protease inhibitor 70 ASONEP TM 70 Phase IIb clinical trials 70 JAK2 Inhibitor 70 Velcade bortezomib 70 compound INCB# 70 Ocrelizumab 70 NV1FGF 70 Daclizumab 70 Spiegelmer ® 70 GSK# [002] 69 refractory chronic lymphocytic 69 IL# PE#QQR 69 Files IND 69 Meets Primary Endpoint 69 multicenter Phase II 69 BLP# Liposome Vaccine 69 MAGE A3 ASCI 69 Temsirolimus 69 RhuDex ® 69 PNT# 69 Investigational Oral 69 RhuDex 69 PSMA ADC 69 pertuzumab 69 antibody MAb 69 Annamycin 69 phase IIa clinical 69 Febuxostat 69 PrevOnco 69 Phase 2b clinical trials 69 delivers fluocinolone acetonide FA 69 oncolytic virus therapies 69 selective estrogen receptor modulator 69 trastuzumab DM1 69 IgG1 monoclonal antibody 69 SPL# Gel vaginal microbicide 69 RhuDex TM 69 vinorelbine tartrate 69 Archexin 69 Pirfenidone 69 Onconase 69 ASONEP ™ 69 Xeloda ® 69 Initiate Phase 69 thalidomide Thalomid 69 progressive metastatic prostate 69 INSPIRE Trial Phase III 69 OncoVex 69 Crofelemer budesonide foam 69 drug figitumumab 69 Tarceva TM 69 ARRY # 69 RhuDex R 69 ATL# [001] 69 Cloretazine ® 69 Phase Ib clinical 69 phase IIb clinical 69 albiglutide 69 Ophthotech 69 metastatic hormone refractory 69 Initiates Clinical 69 mitogen activated ERK kinase 69 Ceflatonin R 69 LymphoStat B belimumab 69 telomerase therapeutic 69 Personalized Immunotherapy 69 Vitrasert R 69 metaglidasen 69 Mipomersen 69 solanezumab 69 metastatic malignant 69 RELOVAIR ™ 69 rasagiline tablets 69 histone deacetylase HDAC inhibitor 69 mGluR2 positive 69 YONDELIS 69 Immunotherapeutic 69 elotuzumab 69 Bayer HealthCare Onyx Pharmaceuticals 69 Sphingomab TM 68 methylnaltrexone bromide 68 Atrasentan 68 ALN VSP Phase 68 MKC# MKC# PP 68 Aplidin 68 Phase Ib II 68 CIMZIA r 68 dasatinib Sprycel 68 phase Ib clinical 68 dextromethorphan quinidine 68 EVIZON TM 68 Pfizer Camptosar 68 acetonide FA 68 Vicriviroc 68 AAG geldanamycin analog 68 Ostabolin C TM 68 TLK# 68 CDP# 68 PANVAC VF 68 Humira adalimumab 68 evaluating tivozanib 68 aurora kinase 68 ocrelizumab 68 Novolimus 68 Vascular Disrupting Agent 68 Zybrestat 68 Xcytrin R 68 drug Treanda 68 Receives Orphan Drug Designation 68 Achieves Primary Endpoint 68 Vitaxin 68 gefitinib Iressa 68 Prednisone Against Refractory 68 Torisel temsirolimus 68 phase IIb trial 68 Alnylam Nasdaq ALNY 68 Phase 2b Clinical Trial 68 oral salmon calcitonin 68 lintuzumab SGN 68 Quark Biotech 68 Zorbtive TM 68 HuMax 68 PDE# inhibitors 68 azilsartan medoxomil 68 JAK inhibitor 68 Erbitux ImClone 68 dasatinib Sprycel ® 68 Submits IND 68 etanercept Enbrel 68 Romiplostim 68 EVIZON ™ 68 Ixabepilone 68 Zenvia ™ 68 Risperidone Oral Solution 68 Bezielle 68 phase III isavuconazole 68 Troxatyl 68 Intravitreal 68 Omnitarg 68 molecular imaging radiopharmaceutical 68 Oporia 68 nilotinib Tasigna 68 Paraplatin 68 Hsp# Inhibitor 68 Prestara 68 Pertuzumab 68 sunitinib Sutent 68 humanized therapeutic 68 GlaxoSmithKline Tykerb 68 Erbitux cetuximab 68 Combination REOLYSIN R 68 Pimavanserin 68 Ecallantide 68 KAI Pharmaceuticals 68 investigational oral hepatitis C 68 PLK1 SNALP 68 Valtropin 68 STEDESA 68 R sorafenib tablets 68 BRAF inhibitor 68 lenalidomide Revlimid 68 Kosan dependence 68 TRO# 68 Insegia 68 anti angiogenic agent 68 dimebon latrepirdine 68 alvespimycin 68 adecatumumab MT# 68 Campto 68 psoriasis rheumatoid arthritis 68 R#/MEM # 68 Biomarker Study 68 proteasome inhibitor 68 Myelodysplastic Syndrome MDS 68 IG HCR ;) CO 68 Muraglitazar 68 Safinamide 68 Iloperidone 68 Davanat 68 Proxinium TM 68 IMiDs R 67 Presents Preclinical Data 67 APEX PD 67 evaluating satraplatin 67 Forteo teriparatide 67 HyperAcute 67 DEB# 67 BioSante Pharmaceuticals Announces 67 PNP inhibitor 67 MKC# MT 67 Submits NDA 67 DP VPA 67 Proellex TM 67 Degarelix 67 PRN FDA Approves 67 vapreotide acetate 67 CEQ# 67 compound KOS 67 Phase 1b clinical trials 67 Xcellerated T Cells 67 Kinase Inhibitor 67 Specifid 67 3 registrational trial 67 Corlux 67 intranasal formulation 67 omacetaxine mepesuccinate 67 Successfully Completes Phase 67 Pegloticase 67 apricitabine ATC 67 Granted Orphan Drug 67 Hedgehog Pathway Inhibitor 67 Vectibix panitumumab 67 Squalamine 67 receptor tyrosine kinase inhibitor 67 Neulasta R 67 human IgG1 monoclonal 67 Genentech Rituxan 67 sterile lidocaine patch 67 telomerase inhibitor drug 67 humanised monoclonal antibody 67 Pivotal Phase III 67 phase IIa 67 Gleevec imatinib mesylate 67 AVASTIN 67 Isis Pharma 67 HCV polymerase 67 inhaled AAT 67 alemtuzumab Campath 67 Naglazyme R 67 gemcitabine Gemzar R 67 cetuximab Erbitux R 67 Arzerra ofatumumab 67 Submits Response 67 tramiprosate Alzhemed TM 67 octreotide implant 67 Ceflatonin ® 67 IAP inhibitor 67 OMP #R# 67 Vidaza azacitidine 67 PI3K/Akt pathway inhibitor 67 thetreatment 67 Cloretazine 67 valopicitabine NM# 67 Anti VEGF 67 Panzem NCD 67 JAK3 inhibitor 67 Fx #A 67 selective androgen receptor modulator 67 Phase Ib clinical trials 67 Omacetaxine 67 FOLOTYN ® 67 OvaRex R 67 BRILINTA 67 P#X# antagonist 67 novel oral anticoagulant 67 IMiDs ® 67 investigational protease inhibitor 67 novel VDA molecule 67 KuDOS 67 successfully commercialize Iluvien 67 IV APAP 67 lumiliximab 67 fostamatinib 67 Factor VIIa 67 TRACON Pharmaceuticals 67 BRIM2 67 Celgene Thalomid 67 Toremifene 67 trastuzumab DM1 T DM1 67 ViroChem Pharma Inc. 67 drug GAP #B# 67 EXPAREL TM 67 Phase IIb trials 67 Orencia abatacept 67 ® lenalidomide 67 hyaluronidase enzyme 67 kidney urologic 67 Announces Tentative Approval 67 Olaparib 67 Presents Preclinical 67 Gentamicin Surgical Implant 67 oral prodrug 67 Saxagliptin 67 iSONEP ™ 67 SUTENT ® 67 anti CD3 monoclonal 67 Vinorelbine 67 delivery polymer matrix 67 Tramiprosate ALZHEMED TM 67 Catalyst Biosciences 67 Submits Biologics License Application 67 IMA# 67 sorafenib Nexavar 67 SinuNase TM 67 Nasdaq PGNX today 67 Wellstat 67 Cetuximab Erbitux 67 phase IIb study 67 Theratope 67 Ridaforolimus 67 Simponi golimumab 67 product Fentanyl TAIFUN 67 Bazedoxifene 67 interferon gamma 1b 67 including eniluracil ADH 67 OSI Tarceva 67 Deforolimus 67 MT#/MEDI-# 67 generation purine nucleoside 67 Argatroban 67 Plicera 67 non porcine pancreatic 67 THR beta agonist 67 small molecule tyrosine 67 Angiocept 67 phase Ib 67 Iluvien ® 67 Fibrillex TM 67 Prodarsan R 67 senicapoc 67 ATL# [002] 67 BRIM3 67 IV Busulfex 67 highly selective inhibitor 67 GLPG# 67 HIV integrase inhibitor 67 ocular formulation 67 Dynepo TM 67 2 methoxyestradiol 67 Reports Preclinical Data 67 UPLYSO 67 Aryplase 67 CAMPATH 67 accumulate preferentially 67 gastrin analogue TT 67 allosteric modulator PAM 67 AFREZZA TM 67 Affinitak 67 diabetes irritable bowel 67 vinflunine 67 Prolongs Survival 67 combines bupropion 67 Peginterferon alfa 2b 67 Initiates Phase 2b 66 Exherin 66 Phase IIa trials 66 Novel Oral 66 nasal calcitonin product 66 Panzem 66 Receive Milestone Payment 66 Lung Cancer Drug 66 Zarnestra 66 pralatrexate injection folate analogue 66 regorafenib 66 liposomal formulation 66 trastuzumab Herceptin R 66 huC# DM4 66 tolevamer 66 investigational humanized monoclonal antibody 66 ZOLINZA 66 incyclinide 66 Nasdaq HALO 66 Vertex hepatitis C 66 Regeneron Pharma 66 MGd 66 Capesaris 66 tiapamil 66 oral anti arrhythmic 66 IMiD 66 ALN HPN 66 IIa trial 66 Investigational Treatment 66 GRN# 66 PHX# 66 R lenalidomide 66 FOLFOX6 chemotherapy regimen 66 paclitaxel poliglumex 66 Adenoscan R 66 Vivecon 66 Phase III Pivotal 66 Fludara ® 66 OMAPRO ™ 66 ImmunoGen TAP technology 66 metastatic colorectal 66 Receives Approvable Letter 66 Virulizin 66 Intarcia 66 candidate deforolimus 66 mitoxantrone plus 66 miconazole Lauriad ® 66 BIIB# 66 ASX PGL 66 Nanobody R 66 OvaRex ® MAb 66 rxRNA 66 davalintide 66 Quinamed 66 Multiple Ascending Dose 66 Creabilis Therapeutics 66 ALN PCS 66 Auxilium Pharma 66 adalimumab Humira 66 gamma secretase inhibitor 66 Urocortin 2 66 targeted antifolate 66 Qutenza TM 66 Medivation Inc 66 Oral Calcitonin 66 oral ridaforolimus 66 LungAlert TM 66 PDX pralatrexate 66 ThermoDox R 66 cetuximab Erbitux 66 PKC# 66 glucokinase activator 66 evaluating T DM1 66 MEK inhibitor 66 ProMune 66 SIX RO ROG 66 paclitaxel Taxol ® 66 PEGylated interferon 66 opioid induced bowel dysfunction 66 deforolimus 66 long acting muscarinic 66 gets USFDA nod 66 Stedesa 66 Xenazine ® 66 Ziopharm 66 BrachySil TM 66 Androxal TM 66 seliciclib CYC# 66 ZACTIMA 66 Campath ® 66 Dose Ranging Study 66 Alkeran 66 Epirubicin 66 Alimta pemetrexed 66 Arranon 66 Nasdaq ACHN 66 Panzem ® 66 erlotinib Tarceva ® 66 Adjuvant Treatment 66 Liprotamase 66 SNS# T 66 Ozarelix 66 FoldRx Pharmaceuticals Inc. 66 Launches Generic Version 66 hormone LHRH antagonist 66 Vandetanib 66 small molecule Hedgehog 66 cinacalcet HCl 66 DPX Survivac 66 IMC #B 66 erlotinib Tarceva 66 Files Investigational 66 Wyeth Enbrel 66 ALTROPANE R 66 Receives Milestone Payment 66 Drug Candidate 66 personalized cellular immunotherapy 66 oxaliplatin Eloxatin 66 Dasatinib 66 follicular Non Hodgkin 66 verteporfin 66 PEG SN# 66 ZEVALIN ® 66 TBC# 66 CYT# potent vascular disrupting 66 tubulin inhibitor 66 5 fluorouracil leucovorin 66 factor VIIa 66 platform HDL Mimetic 66 Unit Dose Budesonide 66 radiation sensitizer 66 UVIDEM 66 5 HT4 66 HGS# 66 Licenses Novel 66 KSP inhibitor 66 TNFerade ™ 66 hereditary emphysema 66 formerly LymphoStat B 66 memantine HCl 66 PD LID 66 ularitide 66 COLAZAL R 66 initiated Phase 1b 66 CancerVax Corporation 66 Cimzia certolizumab pegol 66 RNA antagonists 66 Angiotensin Converting Enzyme 66 MOVIPREP R 66 GVAX R 66 bortezomib Velcade 66 anastrozole Arimidex 66 Ostarine ™ 66 oral dihydropyrimidine dehydrogenase DPD 66 pafuramidine maleate 66 investigational antiplatelet agent 66 Ovation Pharmaceuticals Inc. 66 LSE ASM 66 Testosterone MDTS ® 66 GSK '# 66 HCV RNA polymerase 66 Darusentan 66 PEGylated Fab fragment 66 hypoxia selective 66 SPRYCEL ® 66 OPAXIO TM 66 Xinlay 66 Phase lll 66 Elvitegravir 66 GRNVAC1 66 VentiRx Pharmaceuticals 66 BioNumerik 66 dutogliptin 66 hypoxia activated prodrug 66 Chipscreen 66 EndoTAGTM 1 66 CD# CEA 66 Neuvenge 66 Dacogen decitabine 66 Solazed 66 Inhalation Aerosol 66 tafamidis 66 Amrubicin 66 E1 INT TM 66 supplemental biologics 66 Aurora Kinase 66 Telik logo TELINTRA 66 lorvotuzumab mertansine 66 OMNARIS Nasal Spray 66 PTK# 66 phase IIIb 66 Bayer Nexavar 66 PrevOnco ™ 66 Psoriasis Drug 66 Therion Biologics 65 defensin mimetic antibiotic 65 PRT# 65 nitric oxide donating prostaglandin 65 ADVANCE PD 65 Nasdaq BIIB 65 Glypromate 65 Denufosol 65 markets HP Acthar 65 Presents Positive 65 FUSILEV enhances 65 outlicensed 65 CytoFabTM 65 developer Antisoma plc 65 somatostatin analog 65 immunotherapeutic vaccine 65 Prima BioMed 65 Betaseron ® 65 Sanofi Aventis Taxotere 65 rhIGF-I/rhIGFBP-3 65 Kahalalide F 65 Aricept donepezil 65 Friedreich Ataxia FRDA 65 overactive bladder AA# 65 candidate epratuzumab 65 mTOR inhibitor 65 Drug Fails 65 Empatic ™ 65 Telcyta 65 class mGluR5 inhibitor 65 Presents Positive Preclinical 65 BrachySil ™ 65 Teriflunomide 65 Thiarabine 65 Nexavar ® 65 REGN# 65 Campath alemtuzumab 65 ABILIFY ® 65 Nipent R 65 Bosutinib 65 Phase 2b Trial 65 Fulvestrant 65 Taxotere docetaxel 65 EVIZON TM squalamine lactate 65 Tanespimycin 65 Adenosine Therapeutics 65 Amplimexon 65 NASH Huntington 65 Fenretinide 65 Maribavir 65 Bafetinib 65 RNAi Therapeutic 65 Panitumumab 65 PTK ZK 65 Elotuzumab 65 Romidepsin 65 Meritage Pharma 65 KRYSTEXXA TM pegloticase 65 intravenous AAT 65 sargramostim 65 VNP#M 65 fludarabine phosphate 65 brivaracetam 65 ixabepilone 65 HyACT 65 Glufosfamide 65 Anidulafungin 65 HGS ETR1 mapatumumab 65 developing ACAPODENE 65 Syncria 65 Gemzar ® 65 Potelligent Technology 65 ospemifene 65 eritoran 65 Arzerra TM 65 Serdolect ® 65 Loramyc ™ 65 Eribulin 65 epothilones 65 randomized Phase IIb 65 Forodesine 65 Initiate Clinical Trial 65 product candidate Lpathomab 65 nalbuphine ER 65 OHR/AVR# 65 Folfox 65 Vion Pharmaceuticals 65 evaluating mipomersen 65 cyclophosphamide methotrexate 65 Vidaza R 65 BENLYSTA TM 65 Xanafide 65 sapacitabine CYC# 65 EDEMA3 65 Sprycel dasatinib 65 triggers apoptosis programmed 65 INS# [001] 65 Roche Actemra 65 NPC 1C 65 Alfacell proprietary ribonuclease 65 Serostim ® 65 treat chronic sinusitis 65 TRAIL receptor antibody 65 apoptosis inducer 65 Septin9 biomarker 65 Temodar ® 65 non nucleoside HCV 65 Pirespa 65 ImClone Erbitux 65 chimeric monoclonal antibody 65 NASDAQ INFI 65 Paliperidone Palmitate 65 oral picoplatin 65 ALN HTT 65 Sapacitabine 65 Kevetrin TM 65 ofatumumab HuMax CD# 65 label Lipofen R 65 Enhanze 65 Empatic TM 65 Mg Usa 65 KRN# 65 cannabinor 65 Guanilib 65 Azacitidine 65 induced macular edema 65 docetaxel Taxotere ® 65 biologic antibody 65 selective A2A adenosine receptor 65 systemic anaplastic large 65 R MSCRAMM 65 TASKi3 65 chemotherapy FOLFOX 65 evaluating Actimmune 65 RAPTIVA r 65 Sudhir Agrawal D.Phil 65 Testosterone MDTS R 65 squamous non 65 Monoclonal antibody 65 LAF# 65 panitumumab Vectibix 65 Cloretazine VNP#M 65 octreotide acetate 65 dose escalation clinical 65 huN# DM1 65 Naive Patients 65 Aurograb 65 Merck KGaA Erbitux 65 hormone refractory metastatic prostate 65 AEGR 65 OMP #M# 65 aleglitazar 65 Fodosine 65 aldehyde dehydrogenase ALDH2 deficiency 65 topically applied SEPA 65 non resectable metastatic 65 Rilutek 65 miconazole Lauriad R 65 JAK2 inhibitor 65 Syndax Pharmaceuticals Inc. 65 Trelstar R 65 Pazopanib 65 deCODE ProstateCancer TM 65 XL# anticancer compounds 65 Myocet 65 entinostat 65 Onco TCS 65 Cimzia TM 65 ficlatuzumab 65 INCB# [001] 65 Cetrorelix 65 Aliskiren 65 arsenic trioxide injection 65 SNT MC# 65 multi kinase inhibitor 65 Saforis 65 lexidronam injection 65 investigational immunotherapy 65 Bucindolol 65 agonistic human 65 BIM #A# 65 Mirapexin 65 TNFerade TM 65 Rituxan rituximab 65 IMPDH inhibitor 65 Curaxin CBLC# 65 Lixivaptan 65 ABX EGF 65 diarrhea predominant irritable 65 untreated metastatic colorectal 65 Sensipar R 65 R Saizen R 65 antibody trastuzumab 65 pradefovir 65 Vicinium TM 65 Bevacizumab Avastin 65 Rebif ® 65 bevacizumab Avastin ® 65 Therapeutic Competitors Companies 65 GSK# [001] 65 Selective Electrochemical Tumor Ablation 65 Pruvel 65 AKT inhibitor 65 Hematide ™ 65 Sensipar ® 65 Syncria R 65 Zemplar Capsules 65 candidates Dyloject TM 65 POSIDUR TM ELADUR TM 65 M# rationally 65 AEG# 65 Receives Orphan Drug 65 Ceflatonin 65 Prosaptide 65 assessing T DM1 65 Syntonix 65 5 FU capecitabine 65 NB S# strontium malonate 65 proprietary radiolabeled monoclonal 65 ONCONASE R 65 SUPPRELIN R LA 65 Zavesca r 65 Stage IIIB IV 65 Tibotec BVBA 65 Pegintron 65 Tarsa Therapeutics 65 neratinib 65 Hematide ™ peginesatide 65 Asentar 65 HuMax TAC 65 tumor activated prodrug 65 Pivotal Phase 65 BEMA TM LA 65 Medidur TM FA 65 Phase IIb III 65 forodesine 65 basal insulin analogue 65 Iressa gefitinib 65 Exemestane 65 Uvidem 65 Triapine 65 cyclophosphamide chemotherapy 65 Initiated Phase 65 aerosolized AAT 65 sunitinib malate 65 Exelon rivastigmine 65 HCD# [002] 65 Hexvix ® 65 TOCOSOL 65 Fanapt iloperidone 65 pharmacokinetic PK study 65 Addrenex Pharmaceuticals 65 Phase 2a Trial 65 TBC M4 65 Pfizer Selzentry 65 Camptosar ® 65 Aganocide ® 65 Talabostat 65 Anturol TM 64 VIVITROL ® 64 CVac 64 Antibody Drug Conjugate 64 Phase Ib study 64 Phase III Clinical Trial 64 luteinizing hormone releasing 64 Taranabant 64 Initiates Dosing 64 AstraZeneca Targacept 64 sorafenib tablets 64 mapatumumab 64 bortezomib Velcade R 64 Azilect rasagiline 64 Femara letrozole 64 Fesoterodine 64 CHAMPION PCI 64 Shows Promise Against 64 retinal vein occlusion induced 64 EGS# 64 Inc. www.micromet inc.com 64 Raptiva efalizumab 64 Phase III confirmatory 64 CRMD# 64 Aurora kinase inhibitor 64 nilotinib Tasigna ® 64 Aceon 64 tumors GIST 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 evaluating picoplatin 64 Tocosol 64 ILUVIEN ® 64 Tarceva erlotinib 64 ZFP Therapeutics 64 GLP1 INT TM 64 dacetuzumab 64 Grb 2 64 TEMSO 64 Protexia ® 64 AERx iDMS 64 Phase IIA 64 motesanib 64 Eraxis 64 fostamatinib disodium 64 Medidur ™ FA 64 commercialize deforolimus 64 therapeutic monoclonal antibody 64 Cethrin R 64 Phase Ib Clinical Trial 64 cytokine refractory 64 Certolizumab pegol 64 Roche OTC RHHBY 64 5 lipoxygenase activating 64 RezularTM 64 SYN X 64 Excellarate TM 64 HepeX B 64 treat secondary hyperparathyroidism 64 CB2 selective receptor agonist 64 Hormone Refractory Prostate Cancer 64 GPR# agonist 64 ALN TTR 64 Myrexis Inc. 64 Daxas roflumilast 64 multicenter Phase 64 pregabalin Lyrica 64 HuMax EGFr 64 VitiGam 64 include ColorectAlert TM 64 Phase #b/#a 64 adenosine A2A 64 ELADUR ™ 64 Budesonide foam crofelemer 64 Genasense ® oblimersen 64 imatinib Gleevec ® 64 Clolar ® 64 2A receptor agonist 64 PSN# [001] 64 Civacir 64 Salmedix 64 rivastigmine Exelon 64 Luteinizing Hormone Releasing Hormone 64 catheter occlusion 64 Announce License Agreement 64 Entocort 64 Amigal TM 64 FoldRx 64 Elagolix 64 CYT# vascular disrupting 64 goserelin 64 ONCASPAR 64 systemic RNAi therapeutic 64 Firazyr 64 Onalta 64 Bayer Onyx 64 Horizant ™ 64 selective phosphodiesterase 64 fosbretabulin 64 Ventrus 64 R#/MEM 64 GeneICE 64 Nexavar sorafenib tablets 64 WX UK1 64 NS5B polymerase 64 generation PNP inhibitor 64 HuLuc# 64 BUPHENYL R 64 autologous cellular immunotherapy 64 cortisol synthesis 64 rThrombin 64 FivePrime Therapeutics 64 INTEGRILIN R eptifibatide Injection 64 Beyond Advair 64 Epratuzumab 64 Vernakalant 64 corticosteroid dexamethasone 64 Anavex #-# 64 anti PlGF 64 pegylated liposomal doxorubicin 64 small molecule glucokinase 64 constipation predominant irritable bowel 64 relapsed leukemia 64 MKC# 64 Progenics Pharmaceuticals 64 Proleukin 64 FOR FURTHER INFORMATION ABOUT 64 IGF 1R inhibitor 64 HDAC Inhibitor 64 anticancer compound 64 advanced medullary thyroid 64 lomitapide 64 BZL# 64 TRANSDUR ™ 64 Removab 64 ISENTRESS raltegravir 64 Nuvion 64 Ganciclovir 64 Commences Phase 64 HSP# inhibitor 64 Inotek Pharmaceuticals Corporation 64 Targretin capsules 64 humanized interleukin 6 64 oral nucleoside analogue 64 tenofovir emtricitabine 64 HuMax CD4 64 Phase 2a clinical trials 64 REMINYL ® 64 CCX# B 64 olaparib 64 gepirone ER 64 Abbokinase 64 ANYARA 64 negative allosteric modulator